Cargando…

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer

Detalles Bibliográficos
Autores principales:	Kyndi, M, Alsner, J, Hansen, LL, Sørensen, FB, Overgaard, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233600/ http://dx.doi.org/10.1186/bcr1179

Ejemplares similares

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
por: Alsner, J, et al.
Publicado: (2000)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

Association of TP53 gene codon 72 polymorphism with endometriosis risk in Isfahan
por: Nikbakht Dastjerdi, Mehdi, et al.
Publicado: (2013)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients
por: Moe, Svein Erik, et al.
Publicado: (2023)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients
por: Toyama, Tatsuya, et al.
Publicado: (2007)

TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells
por: Altilia, Serena, et al.
Publicado: (2012)

Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis
por: Gonçalves, Meire Luzia, et al.
Publicado: (2014)

The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients
por: BABAEI, Farhad, et al.
Publicado: (2014)

Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes
por: Słomiński, Bartosz, et al.
Publicado: (2021)

Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women
por: Mostaid, Md Shaki, et al.
Publicado: (2021)

Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
por: Hori, Yasuki, et al.
Publicado: (2015)

TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma
por: Mascelli, Samantha, et al.
Publicado: (2016)

Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer
por: Lin, Ying-Mei, et al.
Publicado: (2018)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls
por: Zhuo, Wenlei, et al.
Publicado: (2009)

TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses
por: Lin, Hung-Yu, et al.
Publicado: (2008)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Publicado: (2015)

Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders
por: Li, Huangkai, et al.
Publicado: (2023)

Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis
por: Dong, Zhiyong, et al.
Publicado: (2018)

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer
por: Costa, Sandra, et al.
Publicado: (2008)

Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study
por: Lung, For-Wey, et al.
Publicado: (2009)

The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis
por: Ruan, Xiao-Lan, et al.
Publicado: (2015)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies
por: Rabachini, Tatiana, et al.
Publicado: (2010)

Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia
por: Li, Ming, et al.
Publicado: (2017)

Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis
por: Zeng, Xian-Tao, et al.
Publicado: (2014)

Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome
por: Chan, Ying, et al.
Publicado: (2016)

Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis
por: Han, Pei-Zhen, et al.
Publicado: (2019)

TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status
por: Zhang, Lei, et al.
Publicado: (2018)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
por: Omura, Go, et al.
Publicado: (2017)

The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism
por: Ramos-Araque, Maria E., et al.
Publicado: (2018)

Prognostic significance of TP53 alterations in breast carcinoma.
por: Andersen, T. I., et al.
Publicado: (1993)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pk35riivmgrdgmsnd8jubves57